Cancer Therapeutics Research Group - The Need For CTRG In Asia

The Need For CTRG In Asia

Our Purpose

There exists a need to introduce new cancer therapies into Asia-Pacific.
The epidemiology of cancer in Asians and Caucasians are different.
Hence, there also exists a need to test new drugs in cancers more commonly seen in Asia-Pacific.
Pharmacogenetics may be different in Asians and Caucasians, leading to differences in pharmacokinetics and pharmacodynamics of cancer medication. Asians may experience different side effects and require different drug dosages compared to Caucasians.
Biology and therapeutic sensitivity of cancer in Asians and Caucasians may be different.
Assisting in global drug development by providing high quality data in a timely fashion.

TOP 10 CANCERS IN SINGAPORE, AUSTRALIA, HONG KONG & KOREA

	SINGAPOREAN	AUSTRALIAN	HONG KONG	KOREAN
TOP 10 CANCERS IN MALES	Lung Colon-rectum Liver Stomach Prostate Nasopharynx Skin Lymphoma Bladder Leukemia	Prostate Colon-rectum Lung Melanoma Bladder Lymphoma Head and Neck Stomach Leukemia Kidney	Lung Liver Colon Nasopharynx Prostate Rectum/Anus Stomach Bladder Oesophagus Non-Hodgkin’s Lymphoma	Stomach Hepatoma Lung Colon Bladder Oesophagus Leukemia Prostate Pancreas Laryngeal
TOP 10 CANCERS IN FEMALES	Breast Colon-Rectum Lung Ovary Cervix Stomach Uterus Skin Thyroid Lymphomas	Breast Colon-rectum Melanoma Lung Lymphoma Endometrium Cervix Ovary Leukemia Bladder	Breast Lung Colon Rectum/Anus Cervix Uteri Corpus Uteri Ovary Stomach Liver Thyroid	Stomach Breast Cervix Colon Hepatoma Lung Thyroid Ovary Leukemia Pancreas
PATIENTS REFERENCE AREA	SINGAPORE	AUSTRALIA NEW ZEALAND THE PACIFIC ISLANDS	HONG KONG	SOUTH KOREA UNITED STATES JAPAN
TOTAL POPULATION (APPROX.)	4.0 Million	30 Million	7.5 Million	50 Million

Next >